Same Indication

Midazolam vs Tofacitinib

Midazolam vs Tofacitinib: Overview

This comparison examines the pharmacological differences between Midazolam and Tofacitinib.

Mechanism of Action

Midazolam: Ultra-short-acting benzodiazepine GABA-A receptor positive allosteric modulator.

Tofacitinib: Pan-JAK inhibitor with preference for JAK1 and JAK3 blocking pro-inflammatory cytokine signaling.

Pharmacokinetics

Half-life: Midazolam — 1.5-2.5 hours; Tofacitinib — 3.2 hours.

Chemical Properties

Molecular Formula: Midazolam — C18H13ClFN3; Tofacitinib — C16H20N6O.

Molecular Weight: Midazolam — 325.7670 g/mol; Tofacitinib — 312.3700 g/mol.

Type: Midazolam — Small molecule; Tofacitinib — Small molecule.